National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 489579

History of Changes from the VAERS Wayback Machine

First Appeared on 5/13/2013

VAERS ID: 489579
VAERS Form:
Age:68.0
Sex:Female
Location:Wyoming
Vaccinated:2012-11-21
Onset:2013-03-15
Submitted:2013-04-18
Entered:2013-04-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER (ZOSTAVAX) / MERCK & CO. INC. H018093 / 0 RA / SC

Administered by: Private      Purchased by: Private
Symptoms: Creutzfeldt-Jakob disease, Electroencephalogram abnormal, Erythema, Nuclear magnetic resonance imaging abnormal, Sinus congestion, Terminal state, Ear congestion, CSF test abnormal, Neurological symptom

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died:0000-00-00
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Albuterol, Fluticasone nasal spray, glucosamine, B complex vitamin, Levothyroxine, Lipitor, Omega-3 FA, Singulair, Zyrtec
Current Illness: No
Preexisting Conditions: Hyperlipidemia
Allergies:
Diagnostic Lab Data: MRI, EEG, CSF evaluation all diagnostic of Creutzfeld Jacob Disease.
CDC 'Split Type':

Write-up: This is a concern given the timing of the onset of the second disease. There is no proof of any association but I feel that the condition is so rare that the timing of the Zostavax vaccination needs to be at least mentioned. The patient and her husband received Zostavax injections in Nov 2012. The patient developed a small localized erythematous reaction but her husband developed a full shingles reaction/rash to his right forehead which then cleared without event. In late January 2012 the patient started coming in with complaints about fullness in her ears, sinus congestion. She was treated with antibiotics and finally prednisone. While on prednisone she started to develop neurologic deficits in 3-15-13 that eventually progressed into major neurologic deficits and finally the diagnosis of Creutzfeld-Jacob Disease via MRI, EEG, and CSF evaluation. The patient is receiving comfort care at home as I write this and is expected to die within the next week. I am just concerned about the timing of the vaccination and then onset of symptoms and then diagnosis of CJD within 5 months.


Changed on 7/7/2013

VAERS ID: 489579 Before After
VAERS Form:
Age:68.0
Sex:Female
Location:Wyoming
Vaccinated:2012-11-21
Onset:2013-03-15
Submitted:2013-04-18
Entered:2013-04-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER (ZOSTAVAX) / MERCK & CO. INC. H018093 / 0 RA / SC

Administered by: Private      Purchased by: Private
Symptoms: Creutzfeldt-Jakob disease, Electroencephalogram abnormal, Erythema, Nuclear magnetic resonance imaging abnormal, Sinus congestion, Terminal state, Ear congestion, CSF test abnormal, Neurological symptom

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died:0000-00-00 2013-04-25
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No Yes, days: (blank) 3     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Albuterol, Fluticasone nasal spray, glucosamine, B complex vitamin, Levothyroxine, Lipitor, Omega-3 FA, Singulair, Zyrtec
Current Illness: No
Preexisting Conditions: Hyperlipidemia
Allergies:
Diagnostic Lab Data: MRI, EEG, CSF evaluation all diagnostic of Creutzfeld Jacob Disease.
CDC 'Split Type':

Write-up: This is a concern given the timing of the onset of the second disease. There is no proof of any association but I feel that the condition is so rare that the timing of the Zostavax vaccination needs to be at least mentioned. The patient and her husband received Zostavax injections in Nov 2012. The patient developed a small localized erythematous reaction but her husband developed a full shingles reaction/rash to his right forehead which then cleared without event. In late January 2012 the patient started coming in with complaints about fullness in her ears, sinus congestion. She was treated with antibiotics and finally prednisone. While on prednisone she started to develop neurologic deficits in 3-15-13 that eventually progressed into major neurologic deficits and finally the diagnosis of Creutzfeld-Jacob Disease via MRI, EEG, and CSF evaluation. The patient is receiving comfort care at home as I write this and is expected to die within the next week. I am just concerned about the timing of the vaccination and then onset of symptoms and then diagnosis of CJD within 5 months.


Changed on 9/17/2013

VAERS ID: 489579 Before After
VAERS Form:
Age:68.0
Sex:Female
Location:Wyoming
Vaccinated:2012-11-21
Onset:2013-03-15
Submitted:2013-04-18
Entered:2013-04-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER (ZOSTAVAX) / MERCK & CO. INC. H018093 / 0 RA / SC

Administered by: Private      Purchased by: Private
Symptoms: Alanine aminotransferase increased, Aphasia, Apraxia, Asthenia, Ataxia, Blood chloride increased, Bradykinesia, Cerebellar syndrome, Cerebrovascular accident, Clumsiness, Constipation, Creutzfeldt-Jakob disease, Culture urine positive, Death, Dehydration, Dysarthria, Dysphagia, Dyspnoea, Ear pain, Echocardiogram normal, Electrocardiogram normal, Electroencephalogram abnormal, Encephalopathy, Erythema, Gait disturbance, Hypersomnia, Hypoaesthesia, Hypokinesia, Nuclear magnetic resonance imaging abnormal, Nuclear magnetic resonance imaging brain abnormal, Pain, Posture abnormal, Renal failure acute, Sinus congestion, Speech disorder, Tenderness, Tremor, Ultrasound Doppler, Ultrasound Doppler normal, Urinary tract infection, Urine abnormality, Vasospasm, White blood cell count normal, White blood cells urine positive, Terminal state, Joint range of motion decreased, Balance disorder, Urine leukocyte esterase positive, Conjunctival hyperaemia, Ear congestion, Monocyte percentage increased, Cognitive disorder, Vaccination site erythema, Vaccination site reaction, CSF test abnormal, Neurological symptom, Grip strength decreased, Hypophagia, Fine motor delay, Vaccination site nodule, Upper-airway cough syndrome, Posterior reversible encephalopathy syndrome, Computerised tomogram head normal

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died:2013-04-25
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 3     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Albuterol, Fluticasone nasal spray, glucosamine, B complex vitamin, Levothyroxine, Lipitor, Omega-3 FA, Singulair, Zyrtec
Current Illness: No
Preexisting Conditions: Hyperlipidemia The following information was obtained through follow-up and/or provided by the government. PMH: hypothyroidism, hyperlipidemia, allergic rhinitis, acute maxillary sinusitis, exercise-induced bronchospasm, cellulitis & abscess of face, contact dermatitis, actinic keratosis.
Allergies:
Diagnostic Lab Data: MRI, EEG, CSF evaluation all diagnostic of Creutzfeld Jacob Disease. The following information was obtained through follow-up and/or provided by the government. 4/25/2013 lab/diagnostic records received for DOS 3/15-4/1/2013. CT head, ECG, echo, carotid US WNL. MRI brain: blood flow restriction to cortical regions of lt temoral & parietal lobes. UA: cloudy, WBC 18 (H), leuk esterase (+). Urine cx contaminated. Blood: WBC 6.9 K/mm3 (N), monos 10.2% (H), ALT 44 U/L (H), Cl 108 mmol/L (H). EEG: abnormal slowing c/w moderate possibly 2^ to prion disease w/ hemispheric onset. CSF: (+) for Creutzfeldt-Jakob disease.
CDC 'Split Type':

Write-up: This is a concern given the timing of the onset of the second disease. There is no proof of any association but I feel that the condition is so rare that the timing of the Zostavax vaccination needs to be at least mentioned. The patient and her husband received Zostavax injections in Nov 2012. The patient developed a small localized erythematous reaction but her husband developed a full shingles reaction/rash to his right forehead which then cleared without event. In late January 2012 the patient started coming in with complaints about fullness in her ears, sinus congestion. She was treated with antibiotics and finally prednisone. While on prednisone she started to develop neurologic deficits in 3-15-13 that eventually progressed into major neurologic deficits and finally the diagnosis of Creutzfeld-Jacob Disease via MRI, EEG, and CSF evaluation. The patient is receiving comfort care at home as I write this and is expected to die within the next week. I am just concerned about the timing of the vaccination and then onset of symptoms and then diagnosis of CJD within 5 months. The following information was obtained through follow-up and/or provided by the government. 4/25/2013 hospital records received for DOS 3/15-18/2013. D/c Dx''s: 1) posterior reversible encephalopathy syndrome w/ vasospasm (PRES) - the involvement here is moslty in the lt temporal-parietal region w/ a small degree of abnormality on the rt side as well; 2) rt sided hand & speech difficulties are improving at this point; 3) hyperlipidemia by hx - currently well controlled; 4) hypothyroidism - currently euthyroid clinically; 5) UTI - non-hospital acquired. Pt c/o 3-4 day hx rt hand clumsiness, word finding difficulties. Had sinus issues wk prior to admission. PE: mild degenerative changes of extremities, slight drift on rt, word finding difficulties, unable to write w/ rt hand. Admitted for monitoring & evaluation. Condition improving. Pt d/c''d home w/ Rx, care, & f/u instructions. 4/25/2013 PCP records received for DOS 11/26/2012-4/25/2013. Dx: Jakob-Creutzfeldt disease. Pt c/o local reaction (red small knot to injection site) s/p vaccination. 2/11 pt c/o 3 wk hx ear pain, sinus congestion, postnasal drainage. Tx''t: ABX for sinus infection. 3/15 pt c/o ears not cleared, difficulty using rt hand for fine motor skills, if not using hand it closes & curls in flexed position, rt hand numbness, word finding difficulties, balance issues. PE: slight word finding difficulty, slight decreased grip strength rt hand, sclera/conjunctival injection w/o d/c, sinus tender to palpation. Referred to hospital for evaluation. Hospitalized for CVA. Symptoms started 2 days s/p steroid initiation for sinus/ear congestion. 3/28 pt c/o continued aphasia, RUE weakness, balance issues, new onset RLE weakness. Word deficit increased, gait is shuffling & wide. Scheduled for neuro f/u, PT, ST. CSF results returned (+) for Jakob-Creutzfeldt disease. Pt provided palliative care @ home. Pt w/ swallowing difficulties, pain, air hunger, increased sleep, decreased eating/drinking. Died @ home. 4/25/2013 consultant records received for DOS 4/1/2013. Assessment: encephalopathy, unspecified. Pt referred for evaluation of possible CVA, hx as noted above. PE: decreased ROM rt shoulder, unable to pronate rt wrist, decreased flexion rt hip, bradykinesia, unsteady gait, apraxia of speech. Sent for EEG & LP w/ concern for encephalitis or prion disease. 4/25/2013 rehab hospital records received for DOS 4/10-13/2013. D/c Dx''s: 1) Creutzfeldt-Jakob encephalopathy; 2) stroke w/ dominant weakness; 3) dyslipidemia; 4) asthma; 5) constipation. Pt admitted due to worsening rt-sided weakness, aphasia, apraxia, ataxia, cognitive dysfunction. PE: significant expressive & receptive aphasia, limited active range of shoulder forward flexion/abduction, significant dysarthria, moderate dysmetria, tremor (worse in RUE). Marginal improvement w/ therapy. D/c''d home w/ possible hospice care. 5/3/2013 death certificate received for DoD 4/25/2013. COD: 1) acute renal failure/dehydration; 2) Creutzfeldt-Jak


Changed on 3/14/2015

VAERS ID: 489579 Before After
VAERS Form:
Age:68.0
Sex:Female
Location:Wyoming
Vaccinated:2012-11-21
Onset:2013-03-15
Submitted:2013-04-18
Entered:2013-04-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER (ZOSTAVAX) / MERCK & CO. INC. H018093 / 0 RA / SC

Administered by: Private      Purchased by: Private
Symptoms: Alanine aminotransferase increased, Aphasia, Apraxia, Asthenia, Ataxia, Blood chloride increased, Bradykinesia, Cerebellar syndrome, Cerebrovascular accident, Clumsiness, Constipation, Creutzfeldt-Jakob disease, Culture urine positive, Death, Dehydration, Dysarthria, Dysphagia, Dyspnoea, Ear pain, Echocardiogram normal, Electrocardiogram normal, Electroencephalogram abnormal, Encephalopathy, Erythema, Gait disturbance, Hypersomnia, Hypoaesthesia, Hypokinesia, Nuclear magnetic resonance imaging abnormal, Nuclear magnetic resonance imaging brain abnormal, Pain, Posture abnormal, Renal failure acute, Sinus congestion, Speech disorder, Tenderness, Tremor, Ultrasound Doppler, Ultrasound Doppler normal, Urinary tract infection, Urine abnormality, Vasospasm, White blood cell count normal, White blood cells urine positive, Terminal state, Joint range of motion decreased, Balance disorder, Urine leukocyte esterase positive, Conjunctival hyperaemia, Ear congestion, Monocyte percentage increased, Cognitive disorder, Vaccination site erythema, Vaccination site reaction, CSF test abnormal, Neurological symptom, Grip strength decreased, Hypophagia, Fine motor delay, Vaccination site nodule, Upper-airway cough syndrome, Posterior reversible encephalopathy syndrome, Computerised tomogram head normal

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died:2013-04-25
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 3     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Albuterol, Fluticasone nasal spray, glucosamine, B complex vitamin, Levothyroxine, Lipitor, Omega-3 FA, Singulair, Zyrtec
Current Illness: No
Preexisting Conditions: Hyperlipidemia The following information was obtained through follow-up and/or provided by the government. PMH: hypothyroidism, hyperlipidemia, allergic rhinitis, acute maxillary sinusitis, exercise-induced bronchospasm, cellulitis & abscess of face, contact dermatitis, actinic keratosis.
Allergies:
Diagnostic Lab Data: MRI, EEG, CSF evaluation all diagnostic of Creutzfeld Jacob Disease. The following information was obtained through follow-up and/or provided by the government. 4/25/2013 lab/diagnostic records received for DOS 3/15-4/1/2013. CT head, ECG, echo, carotid US WNL. MRI brain: blood flow restriction to cortical regions of lt temoral & parietal lobes. UA: cloudy, WBC 18 (H), leuk esterase (+). Urine cx contaminated. Blood: WBC 6.9 K/mm3 (N), monos 10.2% (H), ALT 44 U/L (H), Cl 108 mmol/L (H). EEG: abnormal slowing c/w moderate possibly 2^ to prion disease w/ hemispheric onset. CSF: (+) for Creutzfeldt-Jakob disease.
CDC 'Split Type':

Write-up: This is a concern given the timing of the onset of the second disease. There is no proof of any association but I feel that the condition is so rare that the timing of the Zostavax vaccination needs to be at least mentioned. The patient and her husband received Zostavax injections in Nov 2012. The patient developed a small localized erythematous reaction but her husband developed a full shingles reaction/rash to his right forehead which then cleared without event. In late January 2012 the patient started coming in with complaints about fullness in her ears, sinus congestion. She was treated with antibiotics and finally prednisone. While on prednisone she started to develop neurologic deficits in 3-15-13 that eventually progressed into major neurologic deficits and finally the diagnosis of Creutzfeld-Jacob Disease via MRI, EEG, and CSF evaluation. The patient is receiving comfort care at home as I write this and is expected to die within the next week. I am just concerned about the timing of the vaccination and then onset of symptoms and then diagnosis of CJD within 5 months. The following information was obtained through follow-up and/or provided by the government. 4/25/2013 hospital records received for DOS 3/15-18/2013. D/c Dx''s: 1) posterior reversible encephalopathy syndrome w/ vasospasm (PRES) - the involvement here is moslty in the lt temporal-parietal region w/ a small degree of abnormality on the rt side as well; 2) rt sided hand & speech difficulties are improving at this point; 3) hyperlipidemia by hx - currently well controlled; 4) hypothyroidism - currently euthyroid clinically; 5) UTI - non-hospital acquired. Pt c/o 3-4 day hx rt hand clumsiness, word finding difficulties. Had sinus issues wk prior to admission. PE: mild degenerative changes of extremities, slight drift on rt, word finding difficulties, unable to write w/ rt hand. Admitted for monitoring & evaluation. Condition improving. Pt d/c''d home w/ Rx, care, & f/u instructions. 4/25/2013 PCP records received for DOS 11/26/2012-4/25/2013. Dx: Jakob-Creutzfeldt disease. Pt c/o local reaction (red small knot to injection site) s/p vaccination. 2/11 pt c/o 3 wk hx ear pain, sinus congestion, postnasal drainage. Tx''t: ABX for sinus infection. 3/15 pt c/o ears not cleared, difficulty using rt hand for fine motor skills, if not using hand it closes & curls in flexed position, rt hand numbness, word finding difficulties, balance issues. PE: slight word finding difficulty, slight decreased grip strength rt hand, sclera/conjunctival injection w/o d/c, sinus tender to palpation. Referred to hospital for evaluation. Hospitalized for CVA. Symptoms started 2 days s/p steroid initiation for sinus/ear congestion. 3/28 pt c/o continued aphasia, RUE weakness, balance issues, new onset RLE weakness. Word deficit increased, gait is shuffling & wide. Scheduled for neuro f/u, PT, ST. CSF results returned (+) for Jakob-Creutzfeldt disease. Pt provided palliative care @ home. Pt w/ swallowing difficulties, pain, air hunger, increased sleep, decreased eating/drinking. Died @ home. 4/25/2013 consultant records received for DOS 4/1/2013. Assessment: encephalopathy, unspecified. Pt referred for evaluation of possible CVA, hx as noted above. PE: decreased ROM rt shoulder, unable to pronate rt wrist, decreased flexion rt hip, bradykinesia, unsteady gait, apraxia of speech. Sent for EEG & LP w/ concern for encephalitis or prion disease. 4/25/2013 rehab hospital records received for DOS 4/10-13/2013. D/c Dx''s: 1) Creutzfeldt-Jakob encephalopathy; 2) stroke w/ dominant weakness; 3) dyslipidemia; 4) asthma; 5) constipation. Pt admitted due to worsening rt-sided weakness, aphasia, apraxia, ataxia, cognitive dysfunction. PE: significant expressive & receptive aphasia, limited active range of shoulder forward flexion/abduction, significant dysarthria, moderate dysmetria, tremor (worse in RUE). Marginal improvement w/ therapy. D/c''d home w/ possible hospice care. 5/3/2013 death certificate received for DoD 4/25/2013. COD: 1) acute renal failure/dehydration; 2) Creutzfeldt-Jak


Changed on 9/14/2017

VAERS ID: 489579 Before After
VAERS Form:(blank) 1
Age:68.0
Sex:Female
Location:Wyoming
Vaccinated:2012-11-21
Onset:2013-03-15
Submitted:2013-04-18
Entered:2013-04-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER (ZOSTAVAX) / MERCK & CO. INC. H018093 / 0 1 RA / SC

Administered by: Private      Purchased by: Private
Symptoms: Creutzfeldt-Jakob disease, Electroencephalogram abnormal, Erythema, Nuclear magnetic resonance imaging abnormal, Sinus congestion, Terminal state, Ear congestion, CSF test abnormal, Neurological symptom

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died:2013-04-25
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 3     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Albuterol, Fluticasone nasal spray, glucosamine, B complex vitamin, Levothyroxine, Lipitor, Omega-3 FA, Singulair, Zyrtec
Current Illness: No
Preexisting Conditions: Hyperlipidemia
Allergies:
Diagnostic Lab Data: MRI, EEG, CSF evaluation all diagnostic of Creutzfeld Jacob Disease.
CDC 'Split Type':

Write-up: This is a concern given the timing of the onset of the second disease. There is no proof of any association but I feel that the condition is so rare that the timing of the Zostavax vaccination needs to be at least mentioned. The patient and her husband received Zostavax injections in Nov 2012. The patient developed a small localized erythematous reaction but her husband developed a full shingles reaction/rash to his right forehead which then cleared without event. In late January 2012 the patient started coming in with complaints about fullness in her ears, sinus congestion. She was treated with antibiotics and finally prednisone. While on prednisone she started to develop neurologic deficits in 3-15-13 that eventually progressed into major neurologic deficits and finally the diagnosis of Creutzfeld-Jacob Disease via MRI, EEG, and CSF evaluation. The patient is receiving comfort care at home as I write this and is expected to die within the next week. I am just concerned about the timing of the vaccination and then onset of symptoms and then diagnosis of CJD within 5 months.


Changed on 2/14/2018

VAERS ID: 489579 Before After
VAERS Form:1
Age:68.0
Sex:Female
Location:Wyoming
Vaccinated:2012-11-21
Onset:2013-03-15
Submitted:2013-04-18
Entered:2013-04-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER (ZOSTAVAX) / MERCK & CO. INC. H018093 / 1 RA / SC

Administered by: Private      Purchased by: Private
Symptoms: Creutzfeldt-Jakob disease, Electroencephalogram abnormal, Erythema, Nuclear magnetic resonance imaging abnormal, Sinus congestion, Terminal state, Ear congestion, CSF test abnormal, Neurological symptom

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died:2013-04-25
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 3     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Albuterol, Fluticasone nasal spray, glucosamine, B complex vitamin, Levothyroxine, Lipitor, Omega-3 FA, Singulair, Zyrtec
Current Illness: No
Preexisting Conditions: Hyperlipidemia
Allergies:
Diagnostic Lab Data: MRI, EEG, CSF evaluation all diagnostic of Creutzfeld Jacob Disease.
CDC 'Split Type':

Write-up: This is a concern given the timing of the onset of the second disease. There is no proof of any association but I feel that the condition is so rare that the timing of the Zostavax vaccination needs to be at least mentioned. The patient and her husband received Zostavax injections in Nov 2012. The patient developed a small localized erythematous reaction but her husband developed a full shingles reaction/rash to his right forehead which then cleared without event. In late January 2012 the patient started coming in with complaints about fullness in her ears, sinus congestion. She was treated with antibiotics and finally prednisone. While on prednisone she started to develop neurologic deficits in 3-15-13 that eventually progressed into major neurologic deficits and finally the diagnosis of Creutzfeld-Jacob Disease via MRI, EEG, and CSF evaluation. The patient is receiving comfort care at home as I write this and is expected to die within the next week. I am just concerned about the timing of the vaccination and then onset of symptoms and then diagnosis of CJD within 5 months.


Changed on 6/14/2018

VAERS ID: 489579 Before After
VAERS Form:1
Age:68.0
Sex:Female
Location:Wyoming
Vaccinated:2012-11-21
Onset:2013-03-15
Submitted:2013-04-18
Entered:2013-04-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER (ZOSTAVAX) / MERCK & CO. INC. H018093 / 1 RA / SC

Administered by: Private      Purchased by: Private
Symptoms: Creutzfeldt-Jakob disease, Electroencephalogram abnormal, Erythema, Nuclear magnetic resonance imaging abnormal, Sinus congestion, Terminal state, Ear congestion, CSF test abnormal, Neurological symptom

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died:2013-04-25
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 3     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Albuterol, Fluticasone nasal spray, glucosamine, B complex vitamin, Levothyroxine, Lipitor, Omega-3 FA, Singulair, Zyrtec
Current Illness: No
Preexisting Conditions: Hyperlipidemia
Allergies:
Diagnostic Lab Data: MRI, EEG, CSF evaluation all diagnostic of Creutzfeld Jacob Disease.
CDC 'Split Type':

Write-up: This is a concern given the timing of the onset of the second disease. There is no proof of any association but I feel that the condition is so rare that the timing of the Zostavax vaccination needs to be at least mentioned. The patient and her husband received Zostavax injections in Nov 2012. The patient developed a small localized erythematous reaction but her husband developed a full shingles reaction/rash to his right forehead which then cleared without event. In late January 2012 the patient started coming in with complaints about fullness in her ears, sinus congestion. She was treated with antibiotics and finally prednisone. While on prednisone she started to develop neurologic deficits in 3-15-13 that eventually progressed into major neurologic deficits and finally the diagnosis of Creutzfeld-Jacob Disease via MRI, EEG, and CSF evaluation. The patient is receiving comfort care at home as I write this and is expected to die within the next week. I am just concerned about the timing of the vaccination and then onset of symptoms and then diagnosis of CJD within 5 months.


Changed on 8/14/2018

VAERS ID: 489579 Before After
VAERS Form:1
Age:68.0
Sex:Female
Location:Wyoming
Vaccinated:2012-11-21
Onset:2013-03-15
Submitted:2013-04-18
Entered:2013-04-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER (ZOSTAVAX) / MERCK & CO. INC. H018093 / 1 RA / SC

Administered by: Private      Purchased by: Private
Symptoms: Creutzfeldt-Jakob disease, Electroencephalogram abnormal, Erythema, Nuclear magnetic resonance imaging abnormal, Sinus congestion, Terminal state, Ear congestion, CSF test abnormal, Neurological symptom

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died:2013-04-25
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 3     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Albuterol, Fluticasone nasal spray, glucosamine, B complex vitamin, Levothyroxine, Lipitor, Omega-3 FA, Singulair, Zyrtec
Current Illness: No
Preexisting Conditions: Hyperlipidemia
Allergies:
Diagnostic Lab Data: MRI, EEG, CSF evaluation all diagnostic of Creutzfeld Jacob Disease.
CDC 'Split Type':

Write-up: This is a concern given the timing of the onset of the second disease. There is no proof of any association but I feel that the condition is so rare that the timing of the Zostavax vaccination needs to be at least mentioned. The patient and her husband received Zostavax injections in Nov 2012. The patient developed a small localized erythematous reaction but her husband developed a full shingles reaction/rash to his right forehead which then cleared without event. In late January 2012 the patient started coming in with complaints about fullness in her ears, sinus congestion. She was treated with antibiotics and finally prednisone. While on prednisone she started to develop neurologic deficits in 3-15-13 that eventually progressed into major neurologic deficits and finally the diagnosis of Creutzfeld-Jacob Disease via MRI, EEG, and CSF evaluation. The patient is receiving comfort care at home as I write this and is expected to die within the next week. I am just concerned about the timing of the vaccination and then onset of symptoms and then diagnosis of CJD within 5 months.


Changed on 9/14/2018

VAERS ID: 489579 Before After
VAERS Form:1
Age:68.0
Sex:Female
Location:Wyoming
Vaccinated:2012-11-21
Onset:2013-03-15
Submitted:2013-04-18
Entered:2013-04-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER (ZOSTAVAX) / MERCK & CO. INC. H018093 / 1 RA / SC

Administered by: Private      Purchased by: Private
Symptoms: Creutzfeldt-Jakob disease, Electroencephalogram abnormal, Erythema, Nuclear magnetic resonance imaging abnormal, Sinus congestion, Terminal state, Ear congestion, CSF test abnormal, Neurological symptom

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died:2013-04-25
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 3     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Albuterol, Fluticasone nasal spray, glucosamine, B complex vitamin, Levothyroxine, Lipitor, Omega-3 FA, Singulair, Zyrtec
Current Illness: No
Preexisting Conditions: Hyperlipidemia
Allergies:
Diagnostic Lab Data: MRI, EEG, CSF evaluation all diagnostic of Creutzfeld Jacob Disease.
CDC 'Split Type':

Write-up: This is a concern given the timing of the onset of the second disease. There is no proof of any association but I feel that the condition is so rare that the timing of the Zostavax vaccination needs to be at least mentioned. The patient and her husband received Zostavax injections in Nov 2012. The patient developed a small localized erythematous reaction but her husband developed a full shingles reaction/rash to his right forehead which then cleared without event. In late January 2012 the patient started coming in with complaints about fullness in her ears, sinus congestion. She was treated with antibiotics and finally prednisone. While on prednisone she started to develop neurologic deficits in 3-15-13 that eventually progressed into major neurologic deficits and finally the diagnosis of Creutzfeld-Jacob Disease via MRI, EEG, and CSF evaluation. The patient is receiving comfort care at home as I write this and is expected to die within the next week. I am just concerned about the timing of the vaccination and then onset of symptoms and then diagnosis of CJD within 5 months.


Changed on 10/14/2018

VAERS ID: 489579 Before After
VAERS Form:1
Age:68.0
Sex:Female
Location:Wyoming
Vaccinated:2012-11-21
Onset:2013-03-15
Submitted:2013-04-18
Entered:2013-04-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER (ZOSTAVAX) / MERCK & CO. INC. H018093 / 1 RA / SC

Administered by: Private      Purchased by: Private
Symptoms: Creutzfeldt-Jakob disease, Electroencephalogram abnormal, Erythema, Nuclear magnetic resonance imaging abnormal, Sinus congestion, Terminal state, Ear congestion, CSF test abnormal, Neurological symptom

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died:2013-04-25
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 3     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Albuterol, Fluticasone nasal spray, glucosamine, B complex vitamin, Levothyroxine, Lipitor, Omega-3 FA, Singulair, Zyrtec
Current Illness: No
Preexisting Conditions: Hyperlipidemia
Allergies:
Diagnostic Lab Data: MRI, EEG, CSF evaluation all diagnostic of Creutzfeld Jacob Disease.
CDC 'Split Type':

Write-up: This is a concern given the timing of the onset of the second disease. There is no proof of any association but I feel that the condition is so rare that the timing of the Zostavax vaccination needs to be at least mentioned. The patient and her husband received Zostavax injections in Nov 2012. The patient developed a small localized erythematous reaction but her husband developed a full shingles reaction/rash to his right forehead which then cleared without event. In late January 2012 the patient started coming in with complaints about fullness in her ears, sinus congestion. She was treated with antibiotics and finally prednisone. While on prednisone she started to develop neurologic deficits in 3-15-13 that eventually progressed into major neurologic deficits and finally the diagnosis of Creutzfeld-Jacob Disease via MRI, EEG, and CSF evaluation. The patient is receiving comfort care at home as I write this and is expected to die within the next week. I am just concerned about the timing of the vaccination and then onset of symptoms and then diagnosis of CJD within 5 months.


Changed on 8/14/2019

VAERS ID: 489579 Before After
VAERS Form:1
Age:68.0
Sex:Female
Location:Wyoming
Vaccinated:2012-11-21
Onset:2013-03-15
Submitted:2013-04-18
Entered:2013-04-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER (ZOSTAVAX) ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. H018093 / 1 RA / SC

Administered by: Private      Purchased by: Private
Symptoms: Creutzfeldt-Jakob disease, Electroencephalogram abnormal, Erythema, Nuclear magnetic resonance imaging abnormal, Sinus congestion, Terminal state, Ear congestion, CSF test abnormal, Neurological symptom

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died:2013-04-25
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 3     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Albuterol, Fluticasone nasal spray, glucosamine, B complex vitamin, Levothyroxine, Lipitor, Omega-3 FA, Singulair, Zyrtec
Current Illness: No
Preexisting Conditions: Hyperlipidemia
Allergies:
Diagnostic Lab Data: MRI, EEG, CSF evaluation all diagnostic of Creutzfeld Jacob Disease.
CDC 'Split Type':

Write-up: This is a concern given the timing of the onset of the second disease. There is no proof of any association but I feel that the condition is so rare that the timing of the Zostavax vaccination needs to be at least mentioned. The patient and her husband received Zostavax injections in Nov 2012. The patient developed a small localized erythematous reaction but her husband developed a full shingles reaction/rash to his right forehead which then cleared without event. In late January 2012 the patient started coming in with complaints about fullness in her ears, sinus congestion. She was treated with antibiotics and finally prednisone. While on prednisone she started to develop neurologic deficits in 3-15-13 that eventually progressed into major neurologic deficits and finally the diagnosis of Creutzfeld-Jacob Disease via MRI, EEG, and CSF evaluation. The patient is receiving comfort care at home as I write this and is expected to die within the next week. I am just concerned about the timing of the vaccination and then onset of symptoms and then diagnosis of CJD within 5 months.

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?IDNUMBER=489579&WAYBACKHISTORY=ON


Copyright © 2020 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166